Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-12-28 Purchase |
2022-12-30 4:58 pm |
Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer |
50,000 | $2.845 | $142,250 | 159,930 (Direct) |
View |
| 2022-12-02 Purchase |
2022-12-06 8:31 pm |
Athira Pharma Inc. | ATHA | Romano Kelly A Director |
30,000 | $3.29 | $98,700 | 38,315 (Direct) |
View |
| 2022-11-15 Purchase |
2022-11-17 7:10 pm |
Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer |
5,000 | $3.2884 | $16,442 | 65,836 (Direct) |
View |
| 2022-06-29 Purchase |
2022-07-01 2:24 pm |
Athira Pharma Inc. | ATHA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH Director 10% Owner |
1,371,362 | $2.99 | $4,100,372 | 4,797,278 (Indirect) |
View |
| 2022-06-28 Purchase |
2022-06-30 5:00 pm |
Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer |
10,000 | $2.88 | $28,800 | 52,955 (Direct) |
View |
| 2022-06-23 Sale |
2022-06-24 7:55 pm |
Athira Pharma Inc. | ATHA | Worthington Mark General Counsel |
2,614 | $2.69 | $7,032 | 19,097 (Direct) |
View |
| 2022-06-23 Sale |
2022-06-24 7:53 pm |
Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer |
2,614 | $2.69 | $7,032 | 109,167 (Direct) |
View |
| 2022-06-23 Sale |
2022-06-24 7:51 pm |
Athira Pharma Inc. | ATHA | Litton Mark James Chief Executive Officer |
7,960 | $2.69 | $21,412 | 148,244 (Indirect Direct) |
View |
| 2022-06-23 Sale |
2022-06-24 7:50 pm |
Athira Pharma Inc. | ATHA | Lenington Rachel Chief Operating Officer |
4,193 | $2.69 | $11,279 | 5,807 (Direct) |
View |
| 2022-06-23 Sale |
2022-06-24 7:25 pm |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research |
2,614 | $2.69 | $7,032 | 57,695 (Direct) |
View |
| 2022-03-31 Purchase |
2022-04-01 4:40 pm |
Athira Pharma Inc. | ATHA | Romano Kelly A Director |
8,000 | $13.11 | $104,880 | 8,315 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-01-19 Option Award |
2023-01-23 5:51 pm |
N/A 2033-01-18 |
Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2023-01-19 Option Award |
2023-01-23 5:45 pm |
N/A 2033-01-18 |
Athira Pharma Inc. | ATHA | Lenington Rachel Chief Operating Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2023-01-19 Option Award |
2023-01-23 5:26 pm |
N/A 2033-01-18 |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research |
150,000 | $0 | 212,052 (Direct) |
View |
| 2022-11-18 Option Award |
2023-01-23 5:26 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research |
657 | $2.74 | 212,052 (Direct) |
View |
| 2022-11-18 Option Award |
2022-12-30 4:58 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer |
763 | $2.74 | 159,930 (Direct) |
View |
| 2022-10-28 Exercise |
2022-10-31 8:17 pm |
N/A 2028-12-17 |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research |
3,700 | $0 | 67,805 (Direct) |
View |
| 2022-10-28 Exercise |
2022-10-31 8:17 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research |
3,700 | $1.35 | 67,805 (Direct) |
View |
| 2022-10-13 Exercise |
2022-10-17 6:06 pm |
N/A 2029-08-14 |
Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer |
7,881 | $0 | 68,718 (Direct) |
View |
| 2022-10-13 Exercise |
2022-10-17 6:06 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer |
7,881 | $1.35 | 68,718 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 7:55 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Worthington Mark General Counsel |
10,000 | $0 | 19,097 (Direct) |
View |
| 2022-05-18 Option Award |
2022-06-24 7:55 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Worthington Mark General Counsel |
3,396 | $7.06 | 19,097 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 7:54 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer |
10,000 | $0 | 42,955 (Direct) |
View |
| 2022-05-18 Option Award |
2022-06-24 7:54 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer |
1,699 | $7.06 | 42,955 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 7:53 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer |
10,000 | $0 | 109,167 (Direct) |
View |
| 2022-05-18 Option Award |
2022-06-24 7:53 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer |
1,721 | $7.06 | 109,167 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 7:51 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Litton Mark James Chief Executive Officer |
20,000 | $0 | 148,244 (Direct) |
View |
| 2022-05-18 Option Award |
2022-06-24 7:51 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Litton Mark James Chief Executive Officer |
757 | $7.06 | 148,244 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 7:50 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Lenington Rachel Chief Operating Officer |
10,000 | $0 | 5,807 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 7:25 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research |
10,000 | $0 | 57,695 (Direct) |
View |
| 2022-06-08 Exercise |
2022-06-10 5:53 pm |
N/A 2028-12-17 |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research |
2,500 | $0 | 60,419 (Direct) |
View |
| 2022-05-18 Option Award |
2022-06-10 5:53 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research |
243 | $7.06 | 60,419 (Direct) |
View |
| 2022-06-08 Exercise |
2022-06-10 5:53 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research |
2,500 | $1.35 | 60,419 (Direct) |
View |
| 2022-05-20 Option Award |
2022-05-27 5:51 pm |
N/A 2032-05-19 |
Athira Pharma Inc. | ATHA | PICKERING GRANT Director |
3,467 | $0 | 3,467 (Direct) |
View |
| 2022-05-20 Option Award |
2022-05-27 5:49 pm |
N/A 2032-05-19 |
Athira Pharma Inc. | ATHA | Romano Kelly A Director |
13,871 | $0 | 13,871 (Direct) |
View |
| 2022-05-20 Option Award |
2022-05-27 5:47 pm |
N/A 2032-05-19 |
Athira Pharma Inc. | ATHA | Kosacz Barbara Director |
13,871 | $0 | 13,871 (Direct) |
View |
| 2022-05-20 Option Award |
2022-05-27 5:45 pm |
N/A 2032-05-19 |
Athira Pharma Inc. | ATHA | EDELMAN JOSEPH Director |
13,871 | $0 | 13,871 (Direct) |
View |
| 2022-05-20 Option Award |
2022-05-27 5:42 pm |
N/A 2032-05-19 |
Athira Pharma Inc. | ATHA | FLUKE JOHN M JR Director |
13,871 | $0 | 13,871 (Direct) |
View |
| 2022-05-20 Option Award |
2022-05-27 5:40 pm |
N/A 2032-05-19 |
Athira Pharma Inc. | ATHA | JOHNSON JAMES A Director |
13,871 | $0 | 13,871 (Direct) |
View |
| 2022-05-20 Option Award |
2022-05-27 5:38 pm |
N/A 2032-05-19 |
Athira Pharma Inc. | ATHA | Panzara Michael A. Director |
2,311 | $0 | 2,311 (Direct) |
View |
| 2022-05-20 Option Award |
2022-05-27 5:19 pm |
N/A 2032-05-19 |
Athira Pharma Inc. | ATHA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Director 10% Owner |
13,871 | $0 | 13,871 (Indirect) |
View |
| 2022-04-11 Exercise |
2022-04-12 7:36 pm |
N/A 2032-01-17 |
Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer |
3,000 | $0 | 267,060 (Direct) |
View |
| 2022-04-11 Exercise |
2022-04-12 7:36 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer |
3,000 | $10.64 | 267,060 (Direct) |
View |
| 2022-03-18 Option Award |
2022-03-21 4:40 pm |
N/A 2032-03-17 |
Athira Pharma Inc. | ATHA | Panzara Michael A. Director |
27,742 | $0 | 27,742 (Direct) |
View |
Ownership |
2022-03-21 4:36 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Panzara Michael A. Director |
0 | $0 | 0 (Direct) |
View |
Ownership(A) |
2022-03-21 4:34 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | PICKERING GRANT Director |
0 | $0 | 783 (Direct) |
View |
| 2022-02-18 Exercise |
2022-02-18 7:38 pm |
N/A 2027-06-18 |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research |
3,152 | $0 | 47,566 (Direct) |
View |
| 2022-02-18 Exercise |
2022-02-18 7:38 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research |
3,152 | $1.19 | 47,566 (Direct) |
View |
| 2022-01-27 Option Award |
2022-01-31 5:06 pm |
N/A 2032-01-26 |
Athira Pharma Inc. | ATHA | Litton Mark James Chief Executive Officer |
400,000 | $0 | 535,447 (Direct) |
View |
| 2021-11-18 Option Award |
2022-01-31 5:06 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Litton Mark James Chief Executive Officer |
885 | $12.51 | 535,447 (Direct) |
View |
| 2022-01-27 Option Award |
2022-01-31 5:04 pm |
N/A 2032-01-26 |
Athira Pharma Inc. | ATHA | PICKERING GRANT Director |
27,742 | $0 | 27,742 (Direct) |
View |
Ownership |
2022-01-31 4:59 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | PICKERING GRANT Director |
0 | $0 | 0 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-20 5:31 pm |
N/A 2032-01-17 |
Athira Pharma Inc. | ATHA | Lenington Rachel Chief Operating Officer |
180,000 | $0 | 180,000 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-20 5:28 pm |
N/A 2032-01-17 |
Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer |
170,000 | $0 | 170,000 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-20 5:27 pm |
N/A 2032-01-17 |
Athira Pharma Inc. | ATHA | Worthington Mark General Counsel |
150,000 | $0 | 150,000 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-20 5:25 pm |
N/A 2032-01-17 |
Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer |
180,000 | $0 | 211,256 (Direct) |
View |
| 2021-11-18 Option Award |
2022-01-20 5:25 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer |
829 | $12.51 | 211,256 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-20 5:24 pm |
N/A 2032-01-17 |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research |
100,000 | $0 | 144,414 (Direct) |
View |
| 2021-11-18 Option Award |
2022-01-20 5:24 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research |
96 | $12.51 | 144,414 (Direct) |
View |
| 2022-01-04 Exercise |
2022-01-06 5:08 pm |
N/A 2028-12-17 |
Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer |
6,305 | $0 | 97,060 (Direct) |
View |
| 2021-11-18 Option Award |
2022-01-06 5:08 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer |
931 | $12.51 | 97,060 (Direct) |
View |
| 2022-01-04 Exercise |
2022-01-06 5:08 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer |
6,305 | $1.35 | 97,060 (Direct) |
View |